InvestWiser

BioGaia AB (publ)

BIOG-BNasdaq StockholmHealthcareMarket value 12.4 bn SEK
125.80SEK +0.2%
last day · Price as of 19 November 2026

The answer first

Does BioGaia beat the market?

Yes, BioGaia has beaten the market over the last year.

BioGaia+29.1%Stockholm (OMXSGI)+17.7%
  • The ranking · Quality, value and trend combined

    Better than 72% of Nordic stocks

    • Quality100
    • Value9
    • Trend77

    No. 36 of 195 in healthcare

  • Expectations in the price

    High expectations

    For the share to return about 9% a year from today's price, the cash BioGaia keeps must grow about 18% a year for 10 years.

Max for seven days

Follow BioGaia with Aurora

Aurora lets you know at the next report. No card.

Both with dividends. Figures as of 19 November 2026. General analysis, not personal advice.

Follow your thesis

Follow your thesis on BioGaia

From today, at a price of 125.80 SEK. Write why you follow BioGaia, and choose what Aurora should tell you about.

What should Aurora follow?

Free, no card. The mission is ready when your account is.

Aurora tells you that something happened. What you do is your choice.

Ask Aurora about BioGaia

Your first answer is free, no account needed.

Do you own BioGaia, or are you thinking about it?

See it next to the rest of your portfolio, or build your first one with BioGaia and a few more. Free, no card.

Past year against the exchange and Super Stock
BioGaia+29.1%Stockholm (OMXSGI)+17.7%Super Stock+46.3%
18 November 202519 November 2026
All start at 0 % a year ago, with dividends. Super Stock is our model portfolio: the 20 highest-ranked Nordic stocks on quality, value and trend.

In short

  • BioGaia has risen 29.1% over the past year, including dividends.
  • Overall, BioGaia ranks better than 72% of Nordic stocks on quality, value and trend.
  • The largest fall over the past three years was 29.3%. The price is 6.7% below its peak now.

What do analysts think of BioGaia?

Quality, value and trend

Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.

72

Quality, value and trend together. Better than 72% of Nordic stocks.

No. 36 of 195 in healthcare

Quality100
The company · Fundamentals: the accounts

High A solid company: it earns well on its money and has healthy finances.

No. 2 of 196 in healthcareTypical in healthcare: 64Typical in the Nordics: 50

  • Debt to equityBorrowings divided by equity0.01
  • Asset turnoverSales divided by everything the company owns1.14
  • Return on equityProfit divided by equity+32.0%
  • Cash conversionOperating cash flow divided by profit0.73

The ranking is built on equity ratio, ROA and how steadily profit grows.

Value9
The price · Valuation: the multiples

Low High price: buyers pay a lot today, often because they expect growth.

No. 139 of 197 in healthcareTypical in healthcare: 20Typical in the Nordics: 50

  • P/BPrice divided by equity10.2
  • P/SPrice divided by sales7.6
  • P/EPrice divided by earnings31.9
  • P/CFPrice divided by operating cash flow43.9

The ranking is built on P/E, P/B and P/S.

Trend77
The share price · Technical: the price trend

High Tailwind in the share price: it has risen more than most over the last year.

No. 46 of 198 in healthcareTypical in healthcare: 34Typical in the Nordics: 50

  • 3 months+8.2%
  • 6 months−1.5%
  • 9 months+20.8%
  • 12 months+29.1%

The ranking is built on 3, 6 and 12–1 months.

Return and risk

1 month
+1.5%
3 years, per year
+11.3%
5 years, per year
+7.5%
10 years, per year
+11.2%
Largest fall, 3 years
−29.3%
From a peak to the bottom
From the peak now
−6.7%
How far the price is from the peak
Volatility, 1 year
28.5%
How much the price swings over a year
Beta, 1 year
0.30
How much the price moves when the market moves

Return with dividends reinvested.

The funds that own BioGaia

39 funds we follow own BioGaia. The share is how much of the fund the stock makes up.

  • Norway1
  • Sweden38
  • 1 ETF
  1. TIN Ny Teknik FSweden · TIN6.4%
  2. FIRST Veritas A SEKSweden · FIRST5.2%
  3. Case Gaia MicrocapSweden · Case4.4%
  4. Case All StarSweden · Case3.3%
  5. PLUS Hälsovård Sverige IndexSweden · PLUS3.3%
  6. TIN Småbolag ASweden · TIN3.2%
  7. Aktiespararna Småbolag EdgeSweden · Aktiespararna2.7%
  8. Simplicity Småbolag Sverige ASweden · Simplicity2.3%
Show all 39
  1. Enter Småbolagsfond ASweden · Enter1.8%
  2. Didner & Gerge SmåbolagSweden · Didner1.6%
  3. AMF Aktiefond SmåbolagSweden · AMF1.3%
  4. Öhman Sweden Micro Cap ASweden · Öhman1.2%
  5. Länsförsäkringar Småbolag Sverige ASweden · Länsförsäkringar1.0%
  6. Öhman Sverige Hållbar ASweden · Öhman1.0%
  7. Lysa Sverige Aktier BSweden · Lysa0.9%
  8. Kvartil Nordiska Småbolag+ Faktor ASweden · Kvartil0.7%
  9. Handelsbanken Europa Småbolag (A1 NOK)Sweden · Handelsbanken0.5%
  10. Handelsbanken Europa Småbolag A10 NOKSweden · Handelsbanken0.5%
  11. Lärarfond 21-44 årSweden · Lärarfond0.5%
  12. Xact Svenska Småbolag (UCITS ETF)Sweden · XACT · ETF0.4%
  13. Skandia Småbolag Sverige Exponering ASweden · Skandia0.4%
  14. Lärarfond 45-58 årSweden · Lärarfond0.4%
  15. PLUS Småbolag Sverige IndexSweden · PLUS0.3%
  16. Avanza Sweden All Cap ASweden · Avanza0.2%
  17. Handelsbanken Norden Ind Crit (A1 NOK)Sweden · Handelsbanken0.2%
  18. Lärarfond 59+Sweden · Lärarfond0.2%
  19. Skandia Sverige ExponeringSweden · Skandia0.1%
  20. Simplicity SverigeSweden · Simplicity0.1%
  21. Öhman Etisk Index Sverige ASweden · Öhman0.1%
  22. PLUS Allabolag Sverige IndexSweden · PLUS0.1%
  23. KLP AksjeNorden IndeksNorway · KLP0.1%
  24. Skandia Världen SverigeSweden · Skandia0.1%
  25. Nordea Avtalspensionsfond MidiSweden · Nordea0.0%
  26. Handelsbanken Gl Småbolag I Crit A9 EURSweden · Handelsbanken0.0%
  27. Handelsbanken Gl Småbolag Ind Cri A1 NOKSweden · Handelsbanken0.0%
  28. Nordea Stratega 30Sweden · Nordea0.0%
  29. Nordea Stratega 50Sweden · Nordea0.0%
  30. Nordea Stratega 70Sweden · Nordea0.0%
  31. Skandia SMART FörsiktigSweden · Skandia0.0%

From the funds' latest known holdings.

About BioGaia

BioGaia AB (publ) is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 250 employees.

BioGaia AB (publ), a healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand. It operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula and milk formula. Its Adult Health segment provides gut health tablets, bone health tablets, and oral health lozenges, as well as cultures, which are used as an ingredient in a licensee's dairy product.

See the full analysis of BioGaia.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

Free forever · No card

Other healthcare stocks on Nasdaq Stockholm

Explore the stock market